Pfizer Inc financial data

Symbol
PFE on NYSE
Industry
Pharmaceutical Preparations
Location
66 Hudson Boulevard East, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 95.1 % -44.7%
Quick Ratio 25.2 % -6.59%
Debt-to-equity 144 % +30.3%
Return On Equity 4.69 % -56%
Return On Assets 1.93 % -62%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.67B shares +0.36%
Entity Public Float 207B USD -29.6%
Common Stock, Value, Issued 480M USD +0.42%
Weighted Average Number of Shares Outstanding, Basic 5.67B shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 5.71B shares +1.05%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 59.4B USD -14.3%
Revenue from Contract with Customer, Excluding Assessed Tax 91.8B USD +24.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.9B USD -62.5%
Income Tax Expense (Benefit) -402M USD -347%
Net Income (Loss) Attributable to Parent 4.25B USD -59.4%
Earnings Per Share, Basic 0.76 USD/shares -58.9%
Earnings Per Share, Diluted 0.75 USD/shares -58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.09B USD -65.3%
Accounts Receivable, after Allowance for Credit Loss, Current 14.5B USD +30.4%
Inventory, Net 11.7B USD +14.9%
Other Assets, Current 3.86B USD -16.6%
Assets, Current 43.2B USD -41.6%
Other Long-term Investments 2.18B USD -32.2%
Property, Plant and Equipment, Net 18.5B USD +3.8%
Operating Lease, Right-of-Use Asset 2.92B USD -2.6%
Intangible Assets, Net (Excluding Goodwill) 60B USD +49.1%
Goodwill 68.6B USD +33.1%
Other Assets, Noncurrent 10.5B USD +19.1%
Assets 219B USD +2.07%
Accounts Payable, Current 5.31B USD -0.45%
Employee-related Liabilities, Current 3.38B USD +42.6%
Contract with Customer, Liability, Current 2.02B USD -8.35%
Liabilities, Current 43.2B USD +38.8%
Deferred Income Tax Liabilities, Net 2.16B USD +91.8%
Operating Lease, Liability, Noncurrent 2.63B USD +1.12%
Other Liabilities, Noncurrent 15.6B USD +9.32%
Liabilities 127B USD +7.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.97B USD -0.06%
Retained Earnings (Accumulated Deficit) 121B USD -4.23%
Stockholders' Equity Attributable to Parent 92.3B USD -4.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 92.6B USD -4.78%
Liabilities and Equity 219B USD +2.07%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.09B USD -10.1%
Net Cash Provided by (Used in) Financing Activities -4.93B USD -78%
Net Cash Provided by (Used in) Investing Activities 1.73B USD -47.8%
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 9.56B shares +0.45%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14B USD -222%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.15B USD -64.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 415M USD -0.96%
Deferred Tax Assets, Valuation Allowance 1.74B USD +12.8%
Deferred Tax Assets, Gross 19B USD +28.6%
Operating Lease, Liability 3.15B USD -1.99%
Payments to Acquire Property, Plant, and Equipment 704M USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.25B USD -60.4%
Lessee, Operating Lease, Liability, to be Paid 3.82B USD -0.52%
Property, Plant and Equipment, Gross 35B USD +11.2%
Operating Lease, Liability, Current 527M USD -15%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +33.3%
Deferred Income Tax Expense (Benefit) -441M USD +26.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 671M USD +7.02%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 27M shares 0%
Unrecognized Tax Benefits 4.8B USD +6.85%
Additional Paid in Capital 93.5B USD +1.06%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.3B USD
Depreciation, Depletion and Amortization 1.74B USD +16.7%
Deferred Tax Assets, Net of Valuation Allowance 17.3B USD +30.4%
Interest Expense 3.04B USD +65.8%